// App-Quantinova.ai

TCT-110 : Peri-procedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs. CABG for Left Main Disease: Analysis from the EXCEL Trial

Researchers

Presenter

  • Ori Ben-Yehuda

Principal Investigators

  • Thomas McAndrew

  • Shmuel Chen

  • Bjorn Redfors

  • Ioanna Kosmidou

  • David Kandzari

  • Marie-Claude Morice

  • Martin Leon

  • William Brown

  • Ovidiu Dressler

  • A. Pieter Kappetein

  • Joseph Sabik

  • Patrick Serruys

  • Gregg Stone

Medical Centers

  • Piedmont Heart Institute, Atlanta, Georgia, United States

  • Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, United States

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • CERC, Massy, France

  • Imperial College, London, United Kingdom

  • CRF, New York, New York, United States

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • Cardiovascular Research Foundation, New York, New York, United States

  • Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York, United States

Locations

  • United States

  • Netherlands

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Left main disease

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final